IgG4 Related Disease of the Head and Neck

被引:55
作者
Deshpande V. [1 ]
机构
[1] Departments of Pathology, Massachusetts General Hospital and Harvard Medical School, Warren 2/55 Fruit Street, Boston, 02114, MA
关键词
Eosinophilic angiocentric fibrosis; IgG4; IgG4 related disease; Thyroiditis;
D O I
10.1007/s12105-015-0620-6
中图分类号
学科分类号
摘要
IgG4 related disease of the head and neck region represents one of the more common manifestations of IgG4 related disease. Involvement of the submandibular and parotid glands, the orbit and thyroid represent some of the more common sites involved by IgG4 related disease. Eosinophilic angiocentric fibrosis, Mikulicz disease and Riedel thyroiditis are also members of the family of IgG4 related disease. Clinically, the disease is characterized by tumefactive lesions, often multicentric, that show a swift response to immunosuppressive therapy. An elevated serum IgG4 represents the only validated blood based biomarker. However, elevated serum IgG4 is detected in only half the patients with this disease. Histology continues to represent the gold standard for the diagnosis of IgG4 related disease: storiform-type fibrosis and obliterative phlebitis constitute characteristic features of this disease. A definitive diagnosis of IgG4 related disease also requires the presence of elevated numbers of IgG4 positive plasma cells as well as an IgG4 to IgG ratio of greater than 40 %. In isolation, elevated numbers of IgG4 positive plasma cells represents a non-specific feature, detected in a variety of other inflammatory as well as neoplastic diseases. Attention to the clinical context, histological features, as well as an elevated IgG4 to IgG ratio is critical to avoiding overdiagnosis of IgG4 related disease. © 2015, Springer Science+Business Media New York.
引用
收藏
页码:24 / 31
页数:7
相关论文
共 30 条
[1]  
Mahajan V.S., Mattoo H., Deshpande V., Et al., IgG4-related disease, Annu Rev Pathol, 9, pp. 315-347, (2014)
[2]  
Deshpande V., Zen Y., Chan J.K., Et al., Consensus statement on the pathology of IgG4-related disease, Mod Pathol, 25, pp. 1181-1192, (2012)
[3]  
Li Y., Zhou G., Ozaki T., Et al., Distinct histopathological features of Hashimoto’s thyroiditis with respect to IgG4-related disease, Mod Pathol, 25, pp. 1086-1097, (2012)
[4]  
Deshpande V., Huck A., Ooi E., Et al., Fibrosing variant of Hashimoto thyroiditis is an IgG4 related disease, J Clin Pathol, 65, pp. 725-728, (2012)
[5]  
Stone J.H., Zen Y., Deshpande V., IgG4-related disease, N Engl J Med, 366, pp. 539-551, (2012)
[6]  
Della-Torre E., Mattoo H., Mahajan V.S., Et al., IgG4-related midline destructive lesion, Ann Rheum Dis, 73, pp. 1434-1436, (2014)
[7]  
Stone J.H., IgG4-related disease: nomenclature, clinical features, and treatment, Semin Diagn Pathol, 29, pp. 177-190, (2012)
[8]  
Deshpande V., The pathology of IgG4-related disease: critical issues and challenges, Semin Diagn Pathol, 29, pp. 191-196, (2012)
[9]  
Mattoo H., Mahajan V.S., Della-Torre E., Et al., De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease, J Allergy Clin Immunol, 134, pp. 679-687, (2014)
[10]  
Wallace Z.S., Mattoo H., Carruthers M., Et al., Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations, Ann Rheum Dis, 74, 1, pp. 190-195, (2015)